BBB-on-chip technology recreates the selective blood-brain barrier for CNS drug development, enabling better prediction of brain penetration and neurotoxicity.
Test drug candidates for blood-brain barrier penetration before costly clinical trials.
Model the complete BBB including endothelium, pericytes, astrocytes, and neurons.
Study BBB breakdown in Alzheimer's, stroke, and multiple sclerosis.
Evaluate P-glycoprotein and BCRP interactions that limit CNS drug exposure.
Model neuroinflammation and immune cell trafficking across the BBB.
Screen brain-targeting nanocarriers for CNS drug delivery applications.
Patient Analog connects cutting-edge research with biotech intelligence infrastructure.
Explore Patient AnalogThis premium domain is available for acquisition. Submit your inquiry or make an offer below.